‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone!

Abstract At Risk Mental State (ARMS) clinics are specialised mental health services for young, help-seeking people, thought to be at ultra-high risk of developing psychosis. Their stated purpose is to reduce transitions from the ARMS state to clinical psychotic disorder. Reports of ARMS clinics provide ‘evidence-based recommendations’ or ‘guidance’ for the treatment of such individuals, and claim that such clinics prevent the development of psychosis. However, we note that in an area with a very well-developed ARMS clinic (South London), only a very small proportion (4%) of patients with first episode psychosis had previously been seen at this clinic with symptoms of the ARMS. We conclude that the task of reaching sufficient people to make a major contribution to the prevention of psychosis is beyond the power of ARMS clinics. Following the preventative approaches used for many medical disorders (e.g. lung cancer, coronary artery disease), we consider that a more effective way of preventing psychosis will be to adopt a public health approach; this should attempt to decrease exposure to environmental factors such as cannabis use which are known to increase risk of the disorder.

[1]  T. McGlashan,et al.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.

[2]  I. Falloon,et al.  Early intervention for first episodes of schizophrenia: a preliminary exploration. , 1992, Psychiatry.

[3]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[4]  Alice Mulè,et al.  Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study , 2017, JAMA psychiatry.

[5]  F. Kane,et al.  Social networks and support in first-episode psychosis: exploring the role of loneliness and anxiety , 2014, Social Psychiatry and Psychiatric Epidemiology.

[6]  J. van os,et al.  A critique of the “ultra‐high risk” and “transition” paradigm , 2017, World psychiatry : official journal of the World Psychiatric Association.

[7]  J. Rehm,et al.  Cannabis legalization with strict regulation, the overall superior policy option for public health , 2015, Clinical pharmacology and therapeutics.

[8]  Peter B. Jones,et al.  Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. , 2013, The American journal of psychiatry.

[9]  A. Yung,et al.  Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta‐analysis , 2017, Acta psychiatrica Scandinavica.

[10]  Peter B. Jones,et al.  Psychotic symptoms in young people without psychotic illness: mechanisms and meaning , 2012, British Journal of Psychiatry.

[11]  J. Addington,et al.  Early detection of psychosis: finding those at clinical high risk , 2008, Early intervention in psychiatry.

[12]  M. Hickman,et al.  Association Between Cannabis and Psychosis: Epidemiologic Evidence , 2016, Biological Psychiatry.

[13]  P. Mcguire,et al.  Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis , 2013, European Psychiatry.

[14]  Paola Dazzan,et al.  Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. , 2015, The lancet. Psychiatry.

[15]  Peter B. Jones,et al.  From early intervention in psychosis to youth mental health reform: a review of the evolution and transformation of mental health services for young people , 2016, Social Psychiatry and Psychiatric Epidemiology.

[16]  P. Delespaul,et al.  Toward a world consensus on prevention of schizophrenia , 2005, Dialogues in clinical neuroscience.

[17]  Reddy Ms Attenuated psychosis syndrome. , 2014 .

[18]  R. Kydd,et al.  Early detection and intervention for initial episodes of schizophrenia. , 1996, Schizophrenia bulletin.

[19]  Tyrone D. Cannon,et al.  Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study , 2013, Biological Psychiatry.

[20]  Tyrone D. Cannon,et al.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. , 2009, Schizophrenia bulletin.

[21]  Hok Pan Yuen,et al.  Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.

[22]  Tyrone D. Cannon,et al.  An Individualized Risk Calculator for Research in Prodromal Psychosis. , 2016, The American journal of psychiatry.

[23]  J. van os,et al.  Psychosis as a transdiagnostic and extended phenotype in the general population , 2016, World psychiatry : official journal of the World Psychiatric Association.

[24]  R. Murray,et al.  PAGES_DCNS 46_5.qxd:DCNS#45 , 2010 .

[25]  E. Bramon,et al.  Insight in individuals with an At Risk Mental State , 2007, Schizophrenia Research.

[26]  M. First,et al.  The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk–benefit analysis , 2010, Schizophrenia Research.

[27]  P. Mcguire,et al.  Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment , 2010, Psychological Medicine.

[28]  P. McGuire,et al.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. , 2012, Archives of general psychiatry.

[29]  R. Murray,et al.  What causes psychosis? An umbrella review of risk and protective factors , 2018, World psychiatry : official journal of the World Psychiatric Association.

[30]  A. Yung,et al.  Effectiveness of early intervention in psychosis , 2007, Current opinion in psychiatry.

[31]  S. Wood,et al.  Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention , 2016, Schizophrenia Research.

[32]  Tyrone D. Cannon,et al.  Psychosis risk screening with the Prodromal Questionnaire — Brief Version (PQ-B) , 2011, Schizophrenia Research.

[33]  A. Yung,et al.  Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra–high‐risk service , 2015, Early intervention in psychiatry.

[34]  M. Pruessner,et al.  Outcome in patients converting to psychosis following a treated clinical high risk state , 2018, Early intervention in psychiatry.

[35]  A. David Why we need more debate on whether psychotic symptoms lie on a continuum with normality , 2010, Psychological Medicine.

[36]  P. McGuire,et al.  Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis , 2012, Schizophrenia bulletin.

[37]  I. Hickie,et al.  Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.

[38]  A. Yung,et al.  Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .

[39]  Daniel H. Mathalon,et al.  North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment , 2012, Schizophrenia Research.

[40]  Peter B. Jones,et al.  Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial , 2012, BMJ : British Medical Journal.

[41]  J. Talbott Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment , 2012 .

[42]  A. Yung,et al.  Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people , 2006, Schizophrenia Research.

[43]  G. Dunn,et al.  The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis , 2004, BMJ : British Medical Journal.

[44]  T. Bates,et al.  Designing youth mental health services for the 21st century: examples from Australia, Ireland and the UK , 2013, British Journal of Psychiatry.

[45]  V. Carr Time to move on? Commentary on the early intervention in psychosis debate , 2012, The Australian and New Zealand journal of psychiatry.

[46]  Tyrone D. Cannon,et al.  Comorbid diagnoses for youth at clinical high risk of psychosis , 2017, Schizophrenia Research.

[47]  A. Bechdolf,et al.  Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up , 2008, Schizophrenia Research.

[48]  M. Gaag,et al.  COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions , 2016, Schizophrenia Research.

[49]  Rebecca Cassells,et al.  Is headspace making a difference to young people's lives? , 2016 .

[50]  V. Carr,et al.  Utility of risk-status for predicting psychosis and related outcomes: evaluation of a 10-year cohort of presenters to a specialised early psychosis community mental health service , 2017, Psychiatry Research.

[51]  M. Nordentoft,et al.  Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study) , 2013, British Journal of Psychiatry.

[52]  R. Murray,et al.  Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.

[53]  T. McGlashan Psychosis treatment prior to psychosis onset: ethical issues , 2001, Schizophrenia Research.

[54]  A. David,et al.  Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology , 2016, World psychiatry : official journal of the World Psychiatric Association.

[55]  M. Reddy Attenuated Psychosis Syndrome , 2014, Indian journal of psychological medicine.

[56]  R. Murray,et al.  Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. , 2016, Schizophrenia bulletin.

[57]  R. Bentall,et al.  More harm than good: The case against using antipsychotic drugs to prevent severe mental illness , 2002 .

[58]  A. Malla,et al.  Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample. , 2017, Psychiatric services.

[59]  R. Murray,et al.  Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme , 2017, BMC Psychiatry.

[60]  R. Murray,et al.  Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. , 2006, The British journal of psychiatry : the journal of mental science.

[61]  J. Os,et al.  An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders , 2012, Psychological Medicine.

[62]  R. Murray,et al.  Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. , 2014, Schizophrenia bulletin.

[63]  G C Patton,et al.  Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.

[64]  R. Murray,et al.  Can we identify and treat “schizophrenia light” to prevent true psychotic illness? , 2013, BMJ.

[65]  P. McGuire,et al.  Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase , 2015, British Journal of Psychiatry.

[66]  D. Castle Is it appropriate to treat people at high‐risk of psychosis before first onset? ‐ No , 2012, The Medical journal of Australia.

[67]  S. Wood,et al.  Neuroimaging Findings in the At-Risk Mental State: A Review of Recent Literature , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[68]  C. Carter,et al.  Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. , 2016, The American journal of psychiatry.

[69]  H. Quigley,et al.  Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis , 2016, World psychiatry : official journal of the World Psychiatric Association.

[70]  Tyrone D. Cannon,et al.  Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. , 2015, JAMA psychiatry.

[71]  Robin M. Murray,et al.  The Epidemiology of Schizophrenia , 2004 .

[72]  M. Cannon,et al.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. , 2012, Schizophrenia bulletin.

[73]  Tyrone D. Cannon,et al.  Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk , 2015, Biological Psychiatry.